Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
Clinical trial NCT03311841 · COMPLETED
Trial details
- NCT number
- NCT03311841
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-08-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.